Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Bipolar Disorder
Major Depression

First Posted Date: 2005-09-15

Last Posted Date: 2013-09-10

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 180

Registration Number: NCT00169052

Locations: 🇺🇸
Freedom Trail Clinic, Boston, Massachusetts, United States
🇺🇸
Massachusetts Mental Health Center, Boston, Massachusetts, United States
🇺🇸
Community Council of Nashua, Nashua, New Hampshire, United States

Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers

Phase 1

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Capecitabine
Drug: Docetaxel

First Posted Date: 2005-09-15

Last Posted Date: 2009-08-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 12

Registration Number: NCT00169000

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Alcoholism and Schizophrenia: Effects of Clozapine

Phase 4

Terminated

Conditions: Dual Diagnosis
Substance Abuse
Alcohol Abuse
Schizoaffective Disorder
Psychotic Disorder
Schizophrenia

First Posted Date: 2005-09-15

Last Posted Date: 2018-03-14

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 64

Registration Number: NCT00169026

Locations: 🇺🇸
Commonwealth Research Center, Jamaica Plain, Massachusetts, United States

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

Phase 3

Completed

Conditions: Carcinoma, Non-Small-Cell Lung
Non-small Cell Lung Cancer
NSCLC

Interventions: Drug: Erlotinib (tarceva)
Drug: Placebo

First Posted Date: 2005-09-12

Last Posted Date: 2019-09-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 245

Registration Number: NCT00153803

Locations: 🇺🇸
Birmingham Hematology and Oncology Associates, LLC, Birmingham, Alabama, United States
🇺🇸
Oncology Specialties, P.C., Huntsville, Alabama, United States
🇺🇸
Cooper Clinic, Fort Smith, Arkansas, United States

and more 62 locations

A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer

Phase 1

Terminated

Conditions: Carcinoma, Non-small-cell Lung

Interventions: Drug: Bexarotene (targretin)

First Posted Date: 2005-09-12

Last Posted Date: 2019-03-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 33

Registration Number: NCT00153842

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer

Phase 4

Completed

Conditions: Anemia
Cancer

Interventions: Biological: darbepoetin alfa

First Posted Date: 2005-09-12

Last Posted Date: 2021-09-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 43

Registration Number: NCT00153868

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer

Phase 1

Completed

Conditions: Esophageal Neoplasms

Interventions: Drug: Capecitabine (Xeloda)

First Posted Date: 2005-09-12

Last Posted Date: 2014-11-13

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 44

Registration Number: NCT00153881

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Vitamin D/Calcium Polyp Prevention Study

Phase 2

Completed

Conditions: Polyps
Adenomas
Colorectal Cancer

Interventions: Drug: placebo
Drug: Calcium Carbonate
Drug: Vitamin D3

First Posted Date: 2005-09-12

Last Posted Date: 2017-03-15

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 2813

Registration Number: NCT00153816

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 8 locations

Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder

Phase 4

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Psychotic Disorder
Alcohol Abuse
Substance Abuse

Interventions: Drug: Quetiapine

First Posted Date: 2005-09-12

Last Posted Date: 2018-03-14

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 23

Registration Number: NCT00156715

Locations: 🇺🇸
Medical College of Georgia, Augusta, Georgia, United States
🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸
West Central Behavioral Health, Lebanon, New Hampshire, United States

and more 1 locations

Phase II Study Using Thalidomide for the Treatment of ALS

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis
ALS

First Posted Date: 2005-09-01

Last Posted Date: 2007-11-21

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT00140452

Locations: 🇺🇸
Dartmouth Hichcock Medical Center, Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy